Key facts
- This page summarizes Hui Liu's Form 4 filing for Merus N.V. (MRUS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 09 May 2024, 16:30.
Hui Liu - 07 May 2024 Form 4 Insider Report for Merus N.V. (MRUS)
- Reporting relationship
- EVP, CBO & Head of Merus US
- Issuer ticker
- MRUS
- Reported as of
- 07 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 May 2024, 16:30:40 UTC
- Prior SEC filing
- 11 Oct 2023
- Next SEC filing
- 17 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Peter Silverman as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Hui Liu filed Form 4 for Merus N.V. (MRUS) on 09 May 2024.
Change
- Previous filing in this sequence was filed on 11 Oct 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MRUS
transaction
Derivative
Share Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +107,300
- Change %
- Price
- $0.000000
- Shares after
- 107,300
- Date
- 07 May 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 107,300
- Exercise price
- $36.09
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
On February 1, 2024, the Board of Directors approved the grant of options to purchase the common shares, at an exercise price of $36.09 per share, subject to the Company's general meeting resolving upon, and the Board having implemented through an amendment to the Company's articles of association, an increase in the authorized share capital sufficient to satisfy the award set forth (the "Shareholder Approval Condition"). On May 7, 2024, the shareholders approved the amendment to the Company's articles of association, including the increase in the authorized share capital satisfying the Shareholder Approval Condition.
Footnote F2
Options vest over a four-year period from January 1, 2024. 25% vest on January 1, 2025 and in 36 equal monthly installments thereafter.